Pharmacokinetic and Injection Site Toleration of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects With Type 1 Diabetes
NCT01811849 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2013-03-15
Summary
A Double-blind Study of the Pharmacokinetic Properties of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects with Type 1 Diabetes
Conditions
Interventions
- DRUG
-
Insulin LISPRO
- DRUG
-
Insulin LISPRO
- DRUG
-
Insulin LISPRO
Sponsors & Collaborators
-
Biodel
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
More Related Trials
-
A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus
NCT02562326 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500
NCT02212951 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus
NCT03341299 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Glulisine in Healthy Lean and Obese Subjects
NCT00311077 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus
NCT01364428 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
NCT02298192 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)
NCT00494013 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro
NCT01000922 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes
NCT02273258 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin
NCT00135096 ·Status: COMPLETED ·Phase: PHASE3
-
An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects
NCT02660502 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes
NCT01590836 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes
NCT01849289 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus
NCT01868529 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects
NCT01399255 ·Status: WITHDRAWN ·Phase: PHASE1
-
Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes
NCT01865292 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes
NCT02514850 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus
NCT04501107 ·Status: COMPLETED ·Phase: PHASE1
-
A Study for Patients With Type 1 Diabetes
NCT01049412 ·Status: COMPLETED ·Phase: PHASE2
-
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
NCT04196231 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes Mellitus
NCT01600950 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Lispro Formulations in Healthy Participants
NCT02293551 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of the Response Relationship of NN5401 in Type 1 Diabetics
NCT00993096 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 Diabetes
NCT01569841 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects
NCT01916174 ·Status: COMPLETED ·Phase: PHASE1